SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells

Nucleic Acids Research

Volumn 42, Issue 11, 2014, Pages 6885-6900

  Meneses Morales, Ivan ^a   Tecalco Cruz, Angeles C ^a   Barrios García, Tonatiuh ^a   Gómez Romero, Vania ^a   Trujillo González, Isis ^a   Reyes Carmona, Sandra ^a   García Zepeda, Eduardo ^a   Méndez Enríquez, Erika ^a   Cervantes Roldán, Rafael ^a   Pérez Sánchez, Víctor ^a   Recillas Targa, Félix ^a   Mohar Betancourt, Alejandro ^a   León Del Río, Alfonso ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PDZ PROTEIN; PROTEIN PS2; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR 2 PROTEIN; SODIUM PROTON EXCHANGE PROTEIN; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EXPERIMENTAL THERAPY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MCF 7 CELL LINE; MOUSE; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NUCLEAR RECEPTOR COACTIVATOR 1; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; SODIUM-HYDROGEN ANTIPORTER; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84903150326     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku311     Document Type: Article

References (40)

1. Jordan, V.C. (1995) 'Studies on the estrogen receptor in breast cancer'-20 years as a target for the treatment and prevention of cancer. Breast Cancer Res. Treat., 36, 267-285.
2. Gronemeyer, H. (1991) Transcription activation by estrogen and progesterone receptors. Annu. Rev. Genet., 25, 89-123.
3. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E. and Chambon, P. (1989) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell, 59, 477-487.
4. Tzukerman, M.T., Esty, A., Santiso-Mere, D., Danielian, P., Parker, M.G., Stein, R.B., Pike, J.W. and McDonnell, D.P. (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol., 8, 21-30.
5. Shiau, A.K., Barstad, D., Loria, P.M., Cheng, L., Kushner, P.J., Agard, D.A. and Greene, G.L. (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell, 95, 927-937.
6. Glass, C.K. and Rosenfeld, M.G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev., 14, 121-141.
7. Moras, D. and Gronemeyer, H. (1998) The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol., 10, 384-391.
8. Heery, D.M., Kalkhoven, E., Hoare, S. and Parker, M.G. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature, 387, 733-736.
9. Ito, M., Yuan, C.-X., Malik, S., Gu, W., Fondell, J.D., Yamamura, S., Fu, Z.-Y., Zhang, X., Qin, J. and Roeder, R.G. (1999) Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell, 3, 361-370.
10. Spencer, T.E., Jenster, G., Burcin, M.M., Allis, C.D., Zhou, J., Mizzen, C.A., McKenna, N.J., Onate, S.A., Tsai, S.Y., Tsai, M.-J. et al. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature, 389, 194-198.
11. Green, K.A. and Carroll, J.S. (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat. Rev. Cancer, 7, 713-722.
12. Thompson, E.B. and Kumar, R. (2003) DNA binding of nuclear hormone receptors influences their structure and function. Biochem. Biophys. Res. Commun., 306, 1-4.
13. M?rot, Y., M?tivier, R., Penot, G., Manu, D., Saligaut, C., Gannon, F., Pakdel, F., Kah, O. and Flouriot, G. (2004) The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell. J. Biol. Chem., 279, 26184-26191.
14. Perissi, V. and Rosenfeld, M.G. (2005) Controlling nuclear receptors: the circular logic of cofactor cycles.Nat. Rev. Mol. Cell Biol., 6, 542-554.
15. Colley, S.M., Iyer, K.R. and Leedman, P.J. (2008) The RNA coregulator SRA, its binding proteins and nuclear receptor signaling activity. IUBMB Life, 60, 159-164.
16. Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H. et al. (2001) A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor [alpha] coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J., 20, 1341-1352.
17. Kobayashi, Y., Kitamoto, T., Masuhiro, Y., Watanabe, M., Kase, T., Metzger, D., Yanagisawa, J. and Kato, S. (2000) p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor-and-by interacting directly with the N-terminal A/B domains. J. Biol. Chem., 275, 15645-15651.
18. M?tivier, R., Penot, G., Flouriot, G. and Pakdel, F. (2001) Synergism between ER-transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1-helical core and for a direct interaction between the N-and C-terminal domains. Mol. Endocrinol., 15, 1953-1970.
19. Poulat, F., de Santa Barbara, P., Desclozeaux, M., Soullier, S., Moniot, B., Bonneaud, N., Boizet, B. and Berta, P. (1997) The human testis determining factor SRY binds a nuclear factor containing PDZ protein interaction domains. J. Biol. Chem., 272, 7167-72.
20. Kurashima, K., D'Souza, S., Sz?szi, K., Ramjeesingh, R., Orlowski, J. and Grinstein, S. (1999) The apical Na+/H+ exchanger isoform NHE3 is regulated by the actin cytoskeleton. J. Biol. Chem., 274, 29843-29849.
21. Valadez-Graham, V., Razin, S.V. and Recillas-Targa, F. (2004) CTCF-dependent enhancer blockers at the upstream region of the chicken-globin gene domain. Nucleic Acids Res., 32, 1354-1362.
22. Mitas, M., Mikhitarian, K., Walters, C., Baron, P.L., Elliott, B.M., Brothers, T.E., Robison, J.G., Metcalf, J.S., Palesch, Y.Y., Zhang, Z. et al. (2001) Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer, 93, 162-171.
23. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2?-CT Method. Methods, 25, 402-408.
24. Zhao, C., Yasui, K., Lee, C.J., Kurioka, H., Hosokawa, Y., Oka, T. and Inazawa, J. (2003) Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer, 98, 18-23.
25. Girault, I., Lerebours, F., Amarir, S., Tozlu, S., Tubiana-Hulin, M., Lidereau, R. and Bìeche, I. (2003) Expression analysis of estrogen receptor-coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin. Cancer Res., 9, 1259-1266.
26. Leygue, E., Dotzlaw, H., Watson, P.H. and Murphy, L.C. (1999) Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res., 59, 4190-4193.
27. Fox, S.B., Brown, P., Han, C., Ashe, S., Leek, R.D., Harris, A.L. and Banham, A.H. (2004) Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor-and improved survival in primary human breast carcinomas. Clin. Cancer Res., 10, 3521-3527.
28. Bouras, T., Southey, M.C. and Venter, D.J. (2001) Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res., 61, 903-907.
29. Curtis, C., Shah, S.P., Chin, S.-F., Turashvili, G., Rueda, O.M., Dunning, M.J., Speed, D., Lynch, A.G., Samarajiwa, S., Yuan, Y. et al. (2012) The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature, 486, 346-352.
30. Radvanyi, L., Singh-Sandhu, D., Gallichan, S., Lovitt, C., Pedyczak, A., Mallo, G., Gish, K., Kwok, K., Hanna, W., Zubovits, J. et al. (2005) The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc. Natl. Acad. Sci. U.S.A., 102, 11005-11010.
31. Zhao, H., Langer?, A., Ji, Y., Nowels, K.W., Nesland, J.M., Tibshirani, R., Bukholm, I.K., K?aresen, R., Botstein, D., B?resen-Dale, A.-L. et al. (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell, 15, 2523-2536.
32. Richardson, A.L., Wang, Z.C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J.D., Livingston, D.M. and Ganesan, S. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell, 9, 121-32.
33. Voltz, J.W., Weinman, E.J. and Shenolikar, S. (2001) Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene, 20, 6309-6314.
34. Zhang, J.F.M. (2002) Signaling complex organization by PDZ domain proteins. Neurosignals, 11, 315-321.
35. Harris, B.Z. and Lim, W.A. (2001) Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci., 114, 3219-3231.
36. Fouassier, L., Yun, C.C., Fitz, J.G. and Doctor, R.B. (2000) Evidence for Ezrin-Radixin-Moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions. J. Biol. Chem., 275, 25039-25045.
37. Xu, X.-Z.S., Choudhury, A., Li, X. and Montell, C. (1998) Coordination of an array of signaling proteins through homo-and heteromeric interactions between PDZ domains and target proteins. J. Cell Biol., 142, 545-555.
38. Smith, C.L. and O'Malley, B.W. (2004) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev., 25, 45-71.
39. Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J.M. and Meltzer, P.S. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Sci., 277, 965-968.
40. Xu, J., Wu, R.-C. and O'Malley, B.W. (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer, 9, 615-630.